nodes	percent_of_prediction	percent_of_DWPC	metapath
Pranlukast—TNF—gestational diabetes	0.661	1	CbGaD
Pranlukast—ABCC2—Glyburide—gestational diabetes	0.183	0.653	CbGbCtD
Pranlukast—CYP2C9—Glyburide—gestational diabetes	0.0614	0.219	CbGbCtD
Pranlukast—CYP3A4—Glyburide—gestational diabetes	0.0357	0.128	CbGbCtD
Pranlukast—MUC2—embryo—gestational diabetes	0.00562	0.187	CbGeAlD
Pranlukast—NFKB1—islet of Langerhans—gestational diabetes	0.00331	0.11	CbGeAlD
Pranlukast—TNF—vagina—gestational diabetes	0.00308	0.103	CbGeAlD
Pranlukast—MUC2—head—gestational diabetes	0.00284	0.0948	CbGeAlD
Pranlukast—NFKB1—uterus—gestational diabetes	0.00216	0.0719	CbGeAlD
Pranlukast—CYSLTR1—uterus—gestational diabetes	0.00212	0.0707	CbGeAlD
Pranlukast—NFKB1—adipose tissue—gestational diabetes	0.00211	0.0704	CbGeAlD
Pranlukast—CYSLTR1—adipose tissue—gestational diabetes	0.00207	0.0691	CbGeAlD
Pranlukast—NFKB1—vagina—gestational diabetes	0.00176	0.0585	CbGeAlD
Pranlukast—CYSLTR1—vagina—gestational diabetes	0.00172	0.0575	CbGeAlD
Pranlukast—NFKB1—head—gestational diabetes	0.00162	0.054	CbGeAlD
Pranlukast—CYSLTR1—head—gestational diabetes	0.00159	0.0531	CbGeAlD
Pranlukast—TNF—Transcription factor regulation in adipogenesis—ADIPOQ—gestational diabetes	0.00115	0.0393	CbGpPWpGaD
Pranlukast—TNF—Type II diabetes mellitus—ADIPOQ—gestational diabetes	0.00115	0.0393	CbGpPWpGaD
Pranlukast—IL5—Regulation of nuclear SMAD2/3 signaling—AR—gestational diabetes	0.00113	0.0386	CbGpPWpGaD
Pranlukast—NFKB1—Leptin signaling pathway—LEPR—gestational diabetes	0.001	0.0342	CbGpPWpGaD
Pranlukast—IL5—Cytokines and Inflammatory Response—TNF—gestational diabetes	0.000906	0.0309	CbGpPWpGaD
Pranlukast—TNF—Transcription factor regulation in adipogenesis—LEP—gestational diabetes	0.000714	0.0244	CbGpPWpGaD
Pranlukast—TNF—Adipogenesis—RETN—gestational diabetes	0.000708	0.0242	CbGpPWpGaD
Pranlukast—NFKB1—Transcriptional regulation of white adipocyte differentiation—ADIPOQ—gestational diabetes	0.000554	0.0189	CbGpPWpGaD
Pranlukast—IL5—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—gestational diabetes	0.000553	0.0189	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCRs, Class A Rhodopsin-like—MTNR1B—gestational diabetes	0.00052	0.0178	CbGpPWpGaD
Pranlukast—NFKB1—Regulation of toll-like receptor signaling pathway—MBL2—gestational diabetes	0.000467	0.0159	CbGpPWpGaD
Pranlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—MTNR1B—gestational diabetes	0.000446	0.0152	CbGpPWpGaD
Pranlukast—TNF—Transcriptional regulation of white adipocyte differentiation—ADIPOQ—gestational diabetes	0.000422	0.0144	CbGpPWpGaD
Pranlukast—NFKB1—Canonical NF-kappaB pathway—TNF—gestational diabetes	0.000419	0.0143	CbGpPWpGaD
Pranlukast—NFKB1—EBV LMP1 signaling—TNF—gestational diabetes	0.000419	0.0143	CbGpPWpGaD
Pranlukast—IL5—Allograft Rejection—TNF—gestational diabetes	0.000384	0.0131	CbGpPWpGaD
Pranlukast—NFKB1—SIDS Susceptibility Pathways—GCK—gestational diabetes	0.000382	0.0131	CbGpPWpGaD
Pranlukast—NFKB1—Angiopoietin receptor Tie2-mediated signaling—FGF2—gestational diabetes	0.000369	0.0126	CbGpPWpGaD
Pranlukast—NFKB1—MAPK Signaling Pathway—GCK—gestational diabetes	0.00036	0.0123	CbGpPWpGaD
Pranlukast—TNF—Regulation of toll-like receptor signaling pathway—MBL2—gestational diabetes	0.000356	0.0121	CbGpPWpGaD
Pranlukast—NFKB1—Leptin signaling pathway—LEP—gestational diabetes	0.000351	0.012	CbGpPWpGaD
Pranlukast—NFKB1—Transcriptional regulation of white adipocyte differentiation—LEP—gestational diabetes	0.000344	0.0118	CbGpPWpGaD
Pranlukast—NFKB1—Cardiac Hypertrophic Response—FGF2—gestational diabetes	0.000342	0.0117	CbGpPWpGaD
Pranlukast—TNF—Adipogenesis—NAMPT—gestational diabetes	0.000339	0.0116	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR ligand binding—MTNR1B—gestational diabetes	0.000339	0.0116	CbGpPWpGaD
Pranlukast—NFKB1—amb2 Integrin signaling—TNF—gestational diabetes	0.000321	0.011	CbGpPWpGaD
Pranlukast—NFKB1—HIV-1 Nef: Negative effector of Fas and TNF-alpha—TNF—gestational diabetes	0.000314	0.0107	CbGpPWpGaD
Pranlukast—TNF—SIDS Susceptibility Pathways—GCK—gestational diabetes	0.000291	0.00995	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Breast Cancer Pathway—CYP19A1—gestational diabetes	0.000287	0.0098	CbGpPWpGaD
Pranlukast—NFKB1—IL23-mediated signaling events—TNF—gestational diabetes	0.000286	0.00977	CbGpPWpGaD
Pranlukast—TNF—Angiopoietin receptor Tie2-mediated signaling—FGF2—gestational diabetes	0.000281	0.00961	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Breast Cancer Pathway—AR—gestational diabetes	0.000279	0.00953	CbGpPWpGaD
Pranlukast—TNF—Adipogenesis—ADIPOQ—gestational diabetes	0.000278	0.00948	CbGpPWpGaD
Pranlukast—MUC2—Metabolism of proteins—LEP—gestational diabetes	0.000277	0.00945	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—GCK—gestational diabetes	0.000275	0.00938	CbGpPWpGaD
Pranlukast—NFKB1—SIDS Susceptibility Pathways—AR—gestational diabetes	0.000272	0.00929	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—MTNR1B—gestational diabetes	0.000267	0.00912	CbGpPWpGaD
Pranlukast—TNF—Transcriptional regulation of white adipocyte differentiation—LEP—gestational diabetes	0.000262	0.00895	CbGpPWpGaD
Pranlukast—TNF—Cardiac Hypertrophic Response—FGF2—gestational diabetes	0.000261	0.0089	CbGpPWpGaD
Pranlukast—NFKB1—TWEAK Signaling Pathway—TNF—gestational diabetes	0.000259	0.00883	CbGpPWpGaD
Pranlukast—NFKB1—MicroRNAs in cardiomyocyte hypertrophy—FGF2—gestational diabetes	0.000244	0.00833	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—MTNR1B—gestational diabetes	0.000243	0.00828	CbGpPWpGaD
Pranlukast—NFKB1—Aryl Hydrocarbon Receptor—TNF—gestational diabetes	0.00024	0.00821	CbGpPWpGaD
Pranlukast—NFKB1—TNF receptor signaling pathway —TNF—gestational diabetes	0.00024	0.00821	CbGpPWpGaD
Pranlukast—NFKB1—Ceramide signaling pathway—TNF—gestational diabetes	0.000232	0.00793	CbGpPWpGaD
Pranlukast—CYP2C9—Biological oxidations—GGCT—gestational diabetes	0.000232	0.00792	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—AR—gestational diabetes	0.000231	0.0079	CbGpPWpGaD
Pranlukast—NFKB1—Angiopoietin receptor Tie2-mediated signaling—TNF—gestational diabetes	0.000225	0.00768	CbGpPWpGaD
Pranlukast—NFKB1—Vitamin B12 Metabolism—TNF—gestational diabetes	0.000221	0.00756	CbGpPWpGaD
Pranlukast—NFKB1—Apoptosis-related network due to altered Notch3 in ovarian cancer—TNF—gestational diabetes	0.000215	0.00733	CbGpPWpGaD
Pranlukast—IL5—Immune System—MBL2—gestational diabetes	0.000214	0.00731	CbGpPWpGaD
Pranlukast—NFKB1—TGF-beta Receptor Signaling—TNF—gestational diabetes	0.000211	0.00722	CbGpPWpGaD
Pranlukast—NFKB1—Neural Crest Differentiation—FGF2—gestational diabetes	0.00021	0.00719	CbGpPWpGaD
Pranlukast—NFKB1—Cardiac Hypertrophic Response—TNF—gestational diabetes	0.000208	0.00711	CbGpPWpGaD
Pranlukast—TNF—SIDS Susceptibility Pathways—AR—gestational diabetes	0.000207	0.00708	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—MTNR1B—gestational diabetes	0.000192	0.00655	CbGpPWpGaD
Pranlukast—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.000187	0.0064	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—LEP—gestational diabetes	0.000186	0.00636	CbGpPWpGaD
Pranlukast—TNF—MicroRNAs in cardiomyocyte hypertrophy—FGF2—gestational diabetes	0.000186	0.00634	CbGpPWpGaD
Pranlukast—CYP2C9—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.000185	0.00632	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—LEPR—gestational diabetes	0.000181	0.00619	CbGpPWpGaD
Pranlukast—NFKB1—Folate Metabolism—TNF—gestational diabetes	0.00018	0.00615	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—AR—gestational diabetes	0.000176	0.00602	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—MTNR1B—gestational diabetes	0.000174	0.00594	CbGpPWpGaD
Pranlukast—TNF—Adipogenesis—LEP—gestational diabetes	0.000172	0.00589	CbGpPWpGaD
Pranlukast—NFKB1—Signaling events mediated by HDAC Class I—TNF—gestational diabetes	0.000172	0.00587	CbGpPWpGaD
Pranlukast—NFKB1—Transcriptional regulation of white adipocyte differentiation—TNF—gestational diabetes	0.000159	0.00544	CbGpPWpGaD
Pranlukast—CYP3A4—Biological oxidations—GGCT—gestational diabetes	0.000153	0.00522	CbGpPWpGaD
Pranlukast—CYP3A4—Tryptophan metabolism—CYP19A1—gestational diabetes	0.000153	0.00522	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—GCK—gestational diabetes	0.000152	0.00519	CbGpPWpGaD
Pranlukast—CYP2C9—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.000152	0.00519	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—MBL2—gestational diabetes	0.000149	0.0051	CbGpPWpGaD
Pranlukast—NFKB1—MicroRNAs in cardiomyocyte hypertrophy—TNF—gestational diabetes	0.000148	0.00507	CbGpPWpGaD
Pranlukast—NFKB1—Apoptosis—TNF—gestational diabetes	0.000148	0.00507	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—MTNR1B—gestational diabetes	0.000143	0.00489	CbGpPWpGaD
Pranlukast—NFKB1—Selenium Micronutrient Network—TNF—gestational diabetes	0.000143	0.00489	CbGpPWpGaD
Pranlukast—NFKB1—Downstream signaling events of B Cell Receptor (BCR)—FGF2—gestational diabetes	0.000141	0.00481	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—RBP4—gestational diabetes	0.00014	0.00477	CbGpPWpGaD
Pranlukast—NFKB1—TNF alpha Signaling Pathway—TNF—gestational diabetes	0.000138	0.00471	CbGpPWpGaD
Pranlukast—NFKB1—Fc epsilon receptor (FCERI) signaling—FGF2—gestational diabetes	0.000134	0.00459	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—LEPR—gestational diabetes	0.00013	0.00444	CbGpPWpGaD
Pranlukast—NFKB1—Toll-like Receptor Signaling Pathway—TNF—gestational diabetes	0.000127	0.00434	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—FGF2—gestational diabetes	0.000126	0.00432	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—ADIPOQ—gestational diabetes	0.000125	0.00428	CbGpPWpGaD
Pranlukast—NFKB1—B Cell Activation—FGF2—gestational diabetes	0.000124	0.00424	CbGpPWpGaD
Pranlukast—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.000124	0.00422	CbGpPWpGaD
Pranlukast—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.000122	0.00416	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—GCK—gestational diabetes	0.000116	0.00396	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—MTNR1B—gestational diabetes	0.000103	0.00351	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—RBP4—gestational diabetes	0.0001	0.00342	CbGpPWpGaD
Pranlukast—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.0001	0.00342	CbGpPWpGaD
Pranlukast—NFKB1—Regulation of toll-like receptor signaling pathway—TNF—gestational diabetes	9.92e-05	0.00339	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—FGF2—gestational diabetes	9.63e-05	0.00329	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—ADIPOQ—gestational diabetes	9.54e-05	0.00326	CbGpPWpGaD
Pranlukast—ABCC2—Transmembrane transport of small molecules—GCK—gestational diabetes	9.17e-05	0.00313	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—FGF2—gestational diabetes	9.15e-05	0.00312	CbGpPWpGaD
Pranlukast—NFKB1—SIDS Susceptibility Pathways—TNF—gestational diabetes	9.05e-05	0.00309	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—MBL2—gestational diabetes	8.71e-05	0.00297	CbGpPWpGaD
Pranlukast—NFKB1—MAPK Signaling Pathway—TNF—gestational diabetes	8.53e-05	0.00291	CbGpPWpGaD
Pranlukast—CYP2C9—Biological oxidations—CYP19A1—gestational diabetes	8.07e-05	0.00276	CbGpPWpGaD
Pranlukast—CYP2C9—Metapathway biotransformation—CYP19A1—gestational diabetes	7.96e-05	0.00272	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—LEP—gestational diabetes	7.78e-05	0.00266	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	7.7e-05	0.00263	CbGpPWpGaD
Pranlukast—IL5—Immune System—FGF2—gestational diabetes	7.48e-05	0.00255	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—LEPR—gestational diabetes	7.37e-05	0.00252	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—LEP—gestational diabetes	6.37e-05	0.00217	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—LEP—gestational diabetes	5.93e-05	0.00202	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—FGF2—gestational diabetes	5.91e-05	0.00202	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—MTNR1B—gestational diabetes	5.82e-05	0.00199	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—RBP4—gestational diabetes	5.67e-05	0.00194	CbGpPWpGaD
Pranlukast—CYP3A4—Biological oxidations—CYP19A1—gestational diabetes	5.32e-05	0.00182	CbGpPWpGaD
Pranlukast—CYP3A4—Metapathway biotransformation—CYP19A1—gestational diabetes	5.25e-05	0.00179	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—FGF2—gestational diabetes	5.22e-05	0.00178	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—FGF2—gestational diabetes	5.01e-05	0.00171	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—FGF2—gestational diabetes	4.84e-05	0.00165	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—LEP—gestational diabetes	4.57e-05	0.00156	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—FGF2—gestational diabetes	4.5e-05	0.00154	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—GGCT—gestational diabetes	3.97e-05	0.00135	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—TNF—gestational diabetes	3.6e-05	0.00123	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—FGF2—gestational diabetes	3.47e-05	0.00119	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—GLS2—gestational diabetes	3.47e-05	0.00118	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	3.1e-05	0.00106	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—FGF2—gestational diabetes	3.04e-05	0.00104	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—GGCT—gestational diabetes	2.62e-05	0.000893	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—LEP—gestational diabetes	2.59e-05	0.000883	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—GLS2—gestational diabetes	2.29e-05	0.000781	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—FGF2—gestational diabetes	1.97e-05	0.000671	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—NAMPT—gestational diabetes	1.9e-05	0.000649	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—GCK—gestational diabetes	1.89e-05	0.000645	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—CYP19A1—gestational diabetes	1.38e-05	0.000471	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—NAMPT—gestational diabetes	1.25e-05	0.000428	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—GCK—gestational diabetes	1.24e-05	0.000425	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—CYP19A1—gestational diabetes	9.1e-06	0.000311	CbGpPWpGaD
